Tissue culture plant producer with rare cultivar portfolio seeks strategic equity partner to fuel growth
Licensed tissue culture plant producer with large-scale cloning operation, rare genetics portfolio, a growing export business & state-of-the-art lab facilities seeking $1.5 million "smart money" investment from strategic partner
Listing ID:
9958786864
Licence(s) Held:
Standard Cultivation and CRA license
Listing Details:
State of the art, purpose built, ~26,000 ft.² tissue culture and cultivation facility sitting on 1 acre of land
5,000 ft.² of GMP compliant tissue culture production lab and plantlet production space
Facility is comprised of mother and R&D grow rooms, 6 hardening rooms, tissue culture laboratory, 2x plantlet production rooms, picking and planting line room, separate receiving and quarantine, irrigation room, media preparation room, wash area, secure storage, office rooms, large shipping and packaging room, large clean and sterile room with shipping dock
Currently undertaking mother plant and seed production, phenotyping, tissue culture, cloning, propagation, storage and B2B international exports
Clone capacity - 2.2 million ready to flower plants, 4.7 Million 4”clones and 1.1 Million TC Clones
Company has built an expansive legal genetics catalogue, holding diverse seed and plant stock
Assembled a world class science team with plant-based genetics and cannabis experience
Has one of the largest R&D programs in Canada through its partnerships with multiple institutions
Has a range of breeder and cultivar royalty-type agreements in place
Licence holder also has an exclusive, leading-edge technology for modern tissue culture that improves efficiencies, maximizes production, and reduces operational costs
EU GMP facility in Europe is operational and LP is selling products to various clients and recently made additional shipments to Israel, the UK, and Greece
~10k ft.² of flowering space available to be worked into a deal with a strategic partner: Dried Flower capacity of 4000kg of custom craft flower available for B2B sales
The company has the ability, through strategic partnerships, to offer customized flower genetics, GACP, and flower conversion services in its EUGMP facility in Europe. Additionally, it can distribute its products directly to pharmacies in Germany via a wholesale distributor
Great opportunity to access unique, industry-leading genetics, as well as tissue culture and cloning services to support leading edge cannabis cultivation
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.